A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...

Dr. Mazzone and colleagues report on a cell-free DNA fragmentome assay (DELFIscore) for the classification of lung cancer (1). We have concerns and recommendations. Study participants were enrolled ...

Pulmonologist and advanced bronchoscopist Dr. Eric Swanson points to a lung nodule — which was detected by the Noah Medical Galaxy System at Essentia Health — on a monitor on Thursday, Jan. 29.

DULUTH, Minn. — Essentia Health is combating lung cancer by expanding access to early detection screenings with state-of-the-art equipment. From more staff and hours to a new robot, the Lung Nodule ...

The Essentia Health-Duluth Clinic is improving lung cancer detection through a new cutting-edge robot system and the expansion of a specialty clinic dedicated to early lung cancer detection and ...

1 Department of Software Engineering, University of Engineering and Technology-Taxila, Taxila, Pakistan 2 Information Systems Department, College of Computer and Information Sciences, Imam Mohammad ...

Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company’s AI-enabled radiology platform to help speed up early detection of lung cancer. The ...

Jan 20 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Tuesday it had signed an agreement with Microsoft (MSFT.O), opens new tab to use the tech company's AI-enabled radiology platform ...

Bristol Myers Squibb (BMY) on Tuesday announced a collaboration with Microsoft (MSFT) to speed up early detection of lung cancer using the tech giant’s artificial intelligence-powered radiology ...

Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. The U.S. tech giant will provide its suite of artificial-intelligence-powered radiology ...

Vancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for ...

The disease is the rare cancer met with accusations, not sympathy. By Simar Bajaj Simar Bajaj spoke to over a dozen patients with lung cancer for this story. When Jim Pantelas was diagnosed with lung ...